These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8113327)

  • 1. Effect of metabolic alterations on the accumulation of technetium-99m-labeled d,l-HMPAO in slices of rat cerebral cortex.
    Ahn CS; Tow DE; Yu CC; Greene RW
    J Cereb Blood Flow Metab; 1994 Mar; 14(2):324-31. PubMed ID: 8113327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights on flow-independent mechanisms of 99mTc-HMPAO retention in nervous tissue: in vitro study.
    Colamussi P; Calò G; Sbrenna S; Uccelli L; Bianchi C; Cittanti C; Siniscalchi A; Giganti M; Roveri R; Piffanelli A
    J Nucl Med; 1999 Sep; 40(9):1556-62. PubMed ID: 10492379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 99mTc-HMPAO as a tracer of cerebral blood flow in newborn infants.
    Børch K; Greisen G
    J Cereb Blood Flow Metab; 1997 Apr; 17(4):448-54. PubMed ID: 9143227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 99mTc-D,L-hexamethylene-propyleneamine oxime (99mTc-HMPAO): basic kinetic studies of a tracer of cerebral blood flow.
    Andersen AR
    Cerebrovasc Brain Metab Rev; 1989; 1(4):288-318. PubMed ID: 2701656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of technetium-99m-HMPAO and xenon-133 measurements of regional cerebral blood flow by SPECT.
    Payne JK; Trivedi MH; Devous MD
    J Nucl Med; 1996 Oct; 37(10):1735-40. PubMed ID: 8862321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of antioxidative ability in brain: technetium-99m-meso-HMPAO as an imaging agent for glutathione localization.
    Sasaki T; Toyama H; Oda K; Ogihara-Umeda I; Nishigori H; Senda M
    J Nucl Med; 1996 Oct; 37(10):1698-701. PubMed ID: 8862315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular localization of (99m)Tc-d,l-HMPAO in rat blood.
    Al-Saeedi FJ; Gopinath S
    Med Princ Pract; 2009; 18(6):466-9. PubMed ID: 19797923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake mechanism of technetium-99m-d, 1-HMPAO in cell cultures of the dissociated postnatal rat cerebellum.
    Suess E; Huck S; Reither H; Hörtnagl H; Angelberger P
    J Nucl Med; 1992 Jan; 33(1):108-14. PubMed ID: 1730973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of glutathione localization in brain using 99mTc meso-HMPAO.
    Sasaki T; Senda M
    J Nucl Med; 1999 Jun; 40(6):1056-60. PubMed ID: 10452324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional xenon 133 cerebral blood flow and cerebral technetium 99m HMPAO uptake in unmedicated patients with obsessive-compulsive disorder and matched normal control subjects. Determination by high-resolution single-photon emission computed tomography.
    Rubin RT; Villanueva-Meyer J; Ananth J; Trajmar PG; Mena I
    Arch Gen Psychiatry; 1992 Sep; 49(9):695-702. PubMed ID: 1514874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects.
    Léveillé J; Demonceau G; Walovitch RC
    J Nucl Med; 1992 Apr; 33(4):480-4. PubMed ID: 1552328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retention of [99mTc]-d,l-HM-PAO in rat brain: an autoradiographic study.
    Hoffman TJ; Corlija M; Chaplin SB; Volkert WA; Holmes RA
    J Cereb Blood Flow Metab; 1988 Dec; 8(6):S38-43. PubMed ID: 3192640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of decreased chemotaxis of technetium-99m-HMPAO-labeled lymphocytes to apoptosis.
    Van de Wiele C; Philippé J; Van Haelst JP; Van Damme J; Thierens H; Leroux-Roels GE; Dierckx RA
    J Nucl Med; 1997 Sep; 38(9):1417-21. PubMed ID: 9293800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of the secretion of technetium-99m hexamethylpropylene amine oxime into breast milk.
    Marshall DS; Newberry NR; Ryan PJ
    Eur J Nucl Med; 1996 Dec; 23(12):1634-5. PubMed ID: 8929318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual stimulation increases technetium-99m-HMPAO distribution in human visual cortex.
    Woods SW; Hegeman IM; Zubal IG; Krystal JH; Koster K; Smith EO; Heninger GR; Hoffer PB
    J Nucl Med; 1991 Feb; 32(2):210-5. PubMed ID: 1992020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxido-reductive state: the major determinant for cellular retention of technetium-99m-HMPAO.
    Jacquier-Sarlin MR; Polla BS; Slosman DO
    J Nucl Med; 1996 Aug; 37(8):1413-6. PubMed ID: 8708786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New synthesis route of active substance d,l-HMPAO for preparation Technetium Tc99m Exametazime.
    Pijarowska-Kruszyna J; Karczmarczyk U; Jaroń AW; Laszuk E; Radzik M; Garnuszek P; Mikołajczak R
    Nucl Med Rev Cent East Eur; 2017; 20(2):88-94. PubMed ID: 28555448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity of technetium-99m-d,1-HMPAO to radiolysis in aqueous solutions.
    Tubergen K; Corlija M; Volkert WA; Holmes RA
    J Nucl Med; 1991 Jan; 32(1):111-5. PubMed ID: 1988613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of secondary ion mass spectrometry microscopy for technetium-99m mapping in leukocytes.
    Fourré C; Halpern S; Jeusset J; Clerc J; Fragu P
    J Nucl Med; 1992 Dec; 33(12):2162-6. PubMed ID: 1460510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of technetium-99m hexamethylpropylene amine oxime brain uptake in routine clinical practice using calibrated point sources as an external standard: phantom and human studies.
    Dobbeleir A; Dierckx R
    Eur J Nucl Med; 1993 Aug; 20(8):684-9. PubMed ID: 8404955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.